Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.-Reference-Cited by-同舟云学术

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.

Published:1992-12-12 Issue:6867 Volume:305 Page:1457-1460
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Gustafsson C.,Asplund K.,Britton M.,Norrving B.,Olsson B.,Marke L. A.

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference23 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham study;Wolf, P.A.; Abbott, R.D.; Kannel, W.B.;Stroke,1991

2. Petersen 1';Bovsen, G.;Lancet; Placebocontrolled, randomised, trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study,1989

3. Stroke Presention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation studs: final results;Circtdlationz,1991

4. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. 'I'he effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation;EnglJMed,1990

5. C for the CAFA Study Coinvestigators. Canadian atrial fibrillation (CAFA) study. JAw71 Coll Cardiol;Conollv, S.J.; Laupacis, A.; Gent, I.M.; Roberts, R.S.; Cairns, J.A.; Joyner,1991

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of management of nonvalvular atrial fibrillation in Brazzaville (Congo): preliminary findings;Médecine et Santé Tropicales;2016-04

2. The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods;International Journal of Stroke;2015-08-02

3. Hospital Costs Associated With Atrial Fibrillation for Patients With Ischemic Stroke Aged 18–64 Years in the United States;Stroke;2015-05

4. Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants;PharmacoEconomics;2013-10-02

5. Bleeding as an Outcome Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population;Clinical Therapeutics;2013-10